Patent ID: 12237062

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Detailed embodiments of the present invention are disclosed herein. It will be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms. The figures are not necessarily to scale, and some features may be exaggerated or minimized to show details of particular embodiments, features, or elements. Specific structural and functional details, dimensions, or shapes disclosed herein are not limiting but serve as a basis for the claims and for teaching a person of ordinary skill in the art the described and claimed features of embodiments of the present invention. The following detailed description is merely exemplary in nature and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used herein, the word “exemplary” or “illustrative” means “serving as an example, instance, or illustration.” Any implementation described herein as “exemplary” or “illustrative” is not necessarily to be construed as preferred or advantageous over other implementations. All of the implementations described below are exemplary implementations provided to enable persons skilled in the art to make or use the embodiments of the disclosure and are not intended to limit the scope of the disclosure, which is defined by the claims. For purposes of description herein, the terms “upper”, “lower”, “left”, “rear”, “right”, “front”, “vertical”, “horizontal”, and derivatives thereof shall relate to the invention as oriented inFIG.1. Furthermore, there is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the inventive concepts defined in the appended claims. Hence, specific dimensions and other physical characteristics relating to the embodiments disclosed herein are not to be considered as limiting, unless the claims expressly state otherwise.

It should be noted that references to “an,” “one,” or “various” embodiments in this disclosure are not necessarily to the same embodiment, and such references contemplate more than one embodiment.

The present invention disclosed herein is a contactless automatic pill dispenser configured to remind a user and to dispense medication to the user, and to provide a system for tracking medication compliance.

Unless otherwise defined, all terms of art, notations and other scientific terms or terminology used herein are intended to have the meanings commonly understood by those of skill in the art to which this invention pertains unless the context clearly indicates otherwise. In some cases, terms with commonly understood meanings are defined herein for clarity and/or for ready reference, and the inclusion of such definitions herein should not necessarily be construed to represent a substantial difference over what is generally understood in the art. Many of the techniques and procedures described or referenced herein are well understood and commonly employed using conventional methodology by those skilled in the art, such as, for example, the widely utilized current good manufacturing practice guidelines.

As used herein the term “computing device” includes a desktop, laptop or tablet computer, as well as a mobile device or any other functionally similar device.

As used herein, the terms “patient,” “care giver,” “user,” and the like all refer to the person who is using the present invention and are meant to be interchangeable and non-limiting.

“Telemetry” refers to any wireless transmission and reception of measured quantities for the purpose of remotely monitoring environmental conditions or equipment parameters.

“Software Application” refers to all computer software that causes a computer to perform useful tasks beyond the running of the computer itself.

Disclosed herein and illustrated inFIGS.1through43is a narcotics and Opioids secure storage and dispensing apparatus100(alternatively referred to as a multi-station medication dispensing apparatus), a method of using the narcotics and Opioids secure storage and dispensing apparatus100, ancillary devices associated with the narcotics and Opioids secure storage and dispensing apparatus100, and methods of using the ancillary devices associated with the narcotics and Opioids secure storage and dispensing apparatus100in accordance with the present invention.

A narcotics and Opioids secure storage and dispensing apparatus100is introduced inFIGS.1and2. The shape of the narcotics and Opioids secure storage and dispensing apparatus is generally circular and includes a round primary medication tray110and a similarly rounded secondary medication tray120; each tray110,120having a parallel rounded cover114and a secondary cover124respectively. The round primary medication tray110includes a primary tray medication compartment112. The rounded secondary medication tray120includes a secondary tray medication compartment122. The two compartments112,122house the medication until the medication is dispensed. Each of the primary medication tray110and the secondary medication tray120are rotationally controlled to rotate about a tray rotation axle126. The tray rotation axle126can include sleeved elements to independently control rotation of the primary medication tray110and the secondary medication tray120. Alternatively, motors can directly operate each of the primary medication tray110and the secondary medication tray120, where the primary medication tray110and the secondary medication tray120are designed to rotate about the tray rotation axle126. The primary medication tray110and the secondary medication tray120are preferably nested to one another as illustrated inFIG.5, thus limiting access and removal of the primary medication tray110from the narcotics and Opioids secure storage and dispensing apparatus100.

The secondary cover124may or may not have a port for microphone136and speaker134which is recessed respective to the top cover114. The secondary cover124also houses a secondary tray cover locking harness152and a dual tray cover interconnected locking shaft154which is used to lock the device, preventing unauthorized access and tampering. The narcotics and Opioids secure storage and dispensing apparatus100includes a display unit130used to present a graphical user interface (GUI) for the various functions of the narcotics and Opioids secure storage and dispensing apparatus100and can house a mobile computing device and an Avatar132. The mobile computing device can be embedded into the current setup and maybe a separate detachable unit. The narcotics and Opioids secure storage and dispensing apparatus100can include a set of legs140,142, one in the back (rear supporting leg142) and the other in the front (front supporting leg140). The narcotics and Opioids secure storage and dispensing apparatus100can be charged through charging contacts139. The charging contacts139can also provide a connection to the charging contacts262within each storage shelf260of a storage cart (docking station)250(FIG.15).

Referring toFIGS.3through8, when in use, the narcotics and Opioids secure storage and dispensing apparatus100, the top cover114securely covers the manually loaded medication as well as a sealed blister pack160medication can be placed in the primary medication tray110. Meanwhile, the secondary mediation tray cover124securely covers the secondary medication tray120of the narcotics and Opioids secure storage and dispensing apparatus100which contains manually loaded supplemental medications, vitamins and other pills129. The top cover120further utilizes a tamper proof dual lock mechanism to securely lock access to medication119,129in both the primary medication tray110as well as the secondary medication tray120wherein a motorized shaft securely anchors the access cover124of the inner rotary tray120and furthermore, a plurality of sliding shafts150extend out of the inner rotary tray access cover124and protrude into matching holes (not shown) within outer rotary tray access cover114to interlock and secure the two rotary access covers114,124. The secondary mediation tray cover124for secondary mediation tray120also comprises of an embedded touch display screen130, a microphone136and a speaker134which allow the artificial intelligence avatar132(FIG.8) as well as the remote operators and caregivers to interactively communicate with the user.

The primary medication tray110of the narcotics and Opioids secure storage and dispensing apparatus100, can hold both manually loaded pills119,129as well as a sealed blister pack160(described inFIGS.9through14). The primary medication tray110comprises multiple medication compartments112containing Opioids and other medications119for one or more time instances during a day such as morning, noon, afternoon and evening, as well as one or more days of the week. The primary medication tray110utilizes a motor352to rotate and present the medication stored in each medication compartment at the appropriate time and day of the week. Medication contained within the sealed blister pack160placed in the primary medication tray110can be dispensed utilizing a punch lever118and the supporting motor and electronic356. A medication dispensing schedule for the primary medication tray110, (such as a schedule based upon primary medication119of the Blister pack160) and the secondary medication129dispensed into the secondary supplemental medication tray120of the narcotics and Opioids secure storage and dispensing apparatus100can be programmed locally by utilizing the artificial intelligence Avatar assistant132as well as by remote caregivers and physicians utilizing the wireless module340. The artificial intelligence virtual assistant Avatar132further utilizes text to speech, speech to text and Natural Language Processing NLP326technology to interactively communicate with the user, triage the user and gather relevant information regarding user's health status.

The secondary medication tray120of narcotics and Opioids secure storage and dispensing apparatus100contains manually loaded supplemental medications, vitamins, and other pills129. The secondary medication tray120comprises of multiple medication compartments122containing vitamins, supplemental medication and new additions to regular medication contained in the primary medication try110.

Dispensing of the medications contained in each of the secondary medication tray120compartment122can be programmed to dispense at:a. Simultaneously, with the medication in the primary medication tray compartments at the scheduled time instance such as morning, noon, afternoon and evening, as well as the scheduled day of the week.b. At a pre-programmed time interval prior to the dispensing of the medication in the primary medication tray compartments at the scheduled time instance such as morning, noon, afternoon and evening, as well as the scheduled day of the week.c. At a pre-programmed time interval after the dispensing of the medication in the primary medication tray compartments at the scheduled time instance such as morning, noon, afternoon and evening, as well as the scheduled day of the week

The secondary tray cover124for secondary mediation tray120further comprises an embedded touch display screen130or a mobile device368, such as a mobile phone or a tablet, as well as a microphone136and speaker134, wherein the microphone136and the speaker134allow the artificial intelligence Avatar assistant132as well as the remote operators and caregivers to interactively communicate with the user.

The display unit130of the narcotics and Opioids secure storage and dispensing apparatus100is utilized to schedule, edit and view medication to be dispensed, provide visual communication between the artificial intelligence Avatar assistant132and the user and provide video communication between the user and remotely located operators and caregivers.

The artificial intelligence Avatar assistant132of the narcotics and Opioids secure storage and dispensing apparatus100utilizes text to speech, speech to text and Natural Language Processing (NLP)326technology to interactively communicate with the user, triage the user and gather relevant information regarding user's health status.

The legs140,142can provide several functions. The front supporting leg140of the narcotics and Opioids secure storage and dispensing apparatus100that can be folded closed and snapped in place to allow the device to be carried around.

The rear supporting leg142of the narcotics and Opioids secure storage and dispensing apparatus100that can be folded closed and snapped in place to allow the device to be carried around. The rear leg142can also folded fully open and snapped in place, to be used as a carrying handle for the device.

One or both legs140,142can include a controlled access to a storage cavity provided within an interior of the respective leg140,142. Access to the storage cavity can be provided by a supporting leg storage access element141,143. The supporting leg storage access element141,143is preferably a door which can be pivotally opened, hingeably opened, slideably opened, or opened using any other suitable process. The supporting leg storage access element141,143can be locked with limited access, where the access could be provided via a remote authorization from a counselor, a medical support person, an Emergency Medical Technician (EMT), a nurse, a nurse practitioner, a physician, or any other authorized party. One or more treatments of a suspected overdose counteracting drug148can be storage within the storage cavity. In one example, the suspected overdose counteracting drug148can be NARCAN® provided in either a spray or an injecting delivery format. It is preferred to include at least two treatments of the suspected overdose counteracting drug148within the narcotics and Opioids secure storage and dispensing apparatus100.

Although the illustrated exemplary narcotics and Opioids secure storage and dispensing apparatus100utilizes the legs140,142for storage of the suspected overdose counteracting drug148, the suspected overdose counteracting drug148can be stored in a storage cavity located anywhere on the exemplary narcotics and Opioids secure storage and dispensing apparatus100, including the body, an underside of the body, or any other suitable location.

Access to the storage cavity can be initiated by actuation of a panic button138. The user can actuate the panic button138using any prescribed process. For example, the panic button138can be actuated by depressing the panic button138over an extended period of time (such as 3 seconds). In another example, actuation can be accomplished by simultaneously depressing a pair of spatially arranged panic buttons138.

Upon actuation of the panic button(s)138, the narcotics and Opioids secure storage and dispensing apparatus100can proceed along any of several paths. a first option would be to provide immediate access to the suspected overdose counteracting drug148stored within the narcotics and Opioids secure storage and dispensing apparatus100. A second option would be to initiate access for authorization. The narcotics and Opioids secure storage and dispensing apparatus100would access a predetermined authorizing party, such as a counselor, a medical support person, an Emergency Medical Technician (EMT), a nurse, a nurse practitioner, a physician, or any other authorizing party. The authorizing party would determine whether conditions are appropriate to provide access to the suspected overdose counteracting drug148stored within the narcotics and Opioids secure storage and dispensing apparatus100. The authorizing party can opt to contact the user via the wireless module340of the narcotics and Opioids secure storage and dispensing apparatus100and interact with the user via the user interface360. Alternatively, the authorizing party activate features of the narcotics and Opioids secure storage and dispensing apparatus100to determine the conditions surrounding the narcotics and Opioids secure storage and dispensing apparatus100. Examples of remotely activated features can include microphone136, a medication consumption tracking (fisheye) camera172, a medication dispense monitoring camera174, or any other feature installed on the narcotics and Opioids secure storage and dispensing apparatus100which can acquire information that can aid the authorizing party in determining the conditions of the user and surrounding environment. The medication consumption tracking (fisheye) camera172and the microphone136can be remotely activated, if desired, to record both video and audio following the unwarranted motion. The artificial intelligence avatar132(or any other suitable communication elements) can be activated by a remote party to communicate with one or more persons (such as the user) that would be located proximate the narcotics and Opioids secure storage and dispensing apparatus100as desired.

Access to the suspected overdose counteracting drug148can be provided by any suitable controlled access panel141,143. This can include a motorized access control, a magnetically controlled access operation, a mechanically controlled access operation, a pin controlled access operation, or any other locking and opening access control. Access can also be monitoring by a security monitoring system similar to or the same security monitoring system employed for monitoring security of the narcotics and Opioids secure storage and dispensing apparatus100. It is recognized that access to the suspected overdose counteracting drug148is less concerning than access to the narcotics or Opioids stored within the primary medication tray110. Although the exemplary illustrations present the storage for the suspected overdose counteracting drug148within the legs140,142of the narcotics and Opioids secure storage and dispensing apparatus100, the suspected overdose counteracting drug148can be stored in any reasonable portion of the narcotics and Opioids secure storage and dispensing apparatus100.

The sealed blister pack160, as shown inFIGS.9and10, contains a plurality of blister pack medication compartments162. The sealed blister pack160is also filled and pre-sealed with medication and placed into the primary medication tray110of the narcotics and Opioids secure storage and dispensing apparatus100. A unique punching mechanism then punctures the sealed blister160allowing the pills contained in the blister pack160to be released at appropriate time scheduled.

In the dispense compartment116, another benefit of the narcotics and Opioids secure storage and dispensing apparatus100, is an ability to simultaneously dispense pills that were (a) manually loaded in the primary medication tray110, (b) pills contained in the sealed blister pack160, and supplemental pills manually placed within the secondary medication tray120, thru a common dispense compartment116.

Another feature of the narcotics and Opioids secure storage and dispensing apparatus100is a motorized punching mechanism356detailed inFIGS.11through14. The punch lever118utilizes a dual cutting motion to puncture the sealed blister pack160and dispense the contained medication into the dispense compartment116at scheduled times. In its default normal mode of operation, the punch lever118in fully retracted inside the mechanism center core. To tear open the sealed blister pack160and release the contained medication, the punch lever118is first fully extended out along a straight path creating a straight linear tear in the sealed blister pack160. Once the punch lever118is fully extend out, it will lock in that position while the primary medication compartment110then utilizes the primary medication tray motorized system352to make a rotary move to cover the entire width of one medication compartment112distance. As the result of the secondary rotary movement by the primary medication tray110, the punch lever118will produce a full area tear of the blister pack160for the entire surface of one primary medication tray compartment112. Once the compartment in the blister pack160is breached, the contained medication (primary medication119in a blister pack160of the primary medication tray110or secondary medication129in a blister pack160of the secondary medication tray120), the dispensing medication119,129would follow a path from the respective compartment112,122to the dispense compartment116as best shown inFIG.5.

The charging contacts262located within each storage shelf260of the storage cart250are arranged to create an electrical communication link with the narcotics and Opioids secure storage and dispensing apparatus charging contacts139to enable charging of the narcotics and Opioids secure storage and dispensing apparatus100while the narcotics and Opioids secure storage and dispensing apparatus100is docked. The charging contacts262within each storage shelf260further provide a connection circuitry for the storage cart250to access, log and report the ID, configuration information on each narcotics and Opioids secure storage and dispensing apparatus, as well as the medication dispensed from the primary medication tray110, the secondary medication tray120and the sealed blister pack160.

During operation, the narcotics and Opioids secure storage and dispensing apparatus100can include features to validate the user acquiring the contained medication. For example, the narcotics and Opioids secure storage and dispensing apparatus100can include a medication consumption tracking (fisheye) camera172. The medication consumption tracking (fisheye) camera172can provide a multitude of features. The medication consumption tracking (fisheye) camera172can provide facial recognition of the user for validation of the user via biometrics. Similarly, the medication consumption tracking (fisheye) camera172can provide a function of an iris scanner for validation of the user via biometrics. The medication consumption tracking (fisheye) camera172can also be utilized to identify any unwarranted movement of the narcotics and Opioids secure storage and dispensing apparatus100, such as in a condition where the narcotics and Opioids secure storage and dispensing apparatus100become inverted. Motion sensors can alternative or additionally be utilized for the same or similar function. The medication consumption tracking (fisheye) camera172can be used to track the medication from dispensing through ingestion. This provides a validation process that the patient has actually taken the medication.

Any, a portion, or all video acquired by the medication consumption tracking (fisheye) camera172can be recorded and stored in the memory module320, transmitted to a remote storage media, transmitted to a monitoring party, or transmitted to any other desired recipient (including a portable device associated with a person, a portable device, or a fixed device, or any combination thereof).

A medication dispensing member170provides a controlled access to the dispense compartment116. The medication dispensing member170additionally offers an option for pre-staging of medication (primary medication and/or supplemental medication) within the dispense compartment116prior to dispensing. The medication dispensing member170could be operated using a motor, a cable, hydraulic actuator, a pneumatic actuator, or any other drive mechanism. The medication dispensing member170can open via a hinge along one side, rotated into an open position (similar to the process for opening the bracelet compartment door212), opened via a sliding motion, or any other suitable method of opening an automatically operated member.

One exemplary operation of the medication dispensing door170is illustrated inFIGS.52and53. The primary medication119would be dispensed from the primary medication tray110into the dispense compartment116. In the exemplary illustration inFIG.52, the primary medication119rests upon an upper surface of the medication dispensing door170. Upon approval to dispense the primary medication119, the medication dispensing door170would move in accordance to the designed operation of the medication dispensing door170(shown as a pivoting door) allowing transfer of the primary medication119through a dispensing chute117(as illustrated inFIG.53), and delivering the primary medication119to the user (as illustrated inFIG.8). A scale376can be integrated into the medication dispensing door170, enabling acquisition of a weight of the primary medication119prior to dispensing.

A biometric monitoring sensor176can be provided, preferably at a location proximate the medication dispensing member170, enabling user validation immediately prior to dispensing the medication. Further, in an arrangement where the biometric monitoring sensor176is located adjacent to the medication dispensing member170, opening of the medication dispensing member170can be initiated by the user placing their finger onto the biometric monitoring sensor176, positioning their hand under the medication dispensing member170, retaining their finger in that location while the narcotics and Opioids secure storage and dispensing apparatus100dispenses the medication. A medication dispense monitoring camera174can be integrated into the narcotics and Opioids secure storage and dispensing apparatus100, wherein the medication dispense monitoring camera174is provided to acquire video during the process of dispensing the medication. This can ensure that the medication was received directly by the patient associated with the script. These features are provided to ensure that the medication is to dispense to the patient and only to the patient. The medication dispense monitoring camera174can function in conjunction with the medication consumption tracking (fisheye) camera172to acquire video from the time where the medication is dispensed through the time where the medication is ingested. The medication consumption tracking (fisheye) camera172can be replicated about a circumference of the body of the narcotics and Opioids secure storage and dispensing apparatus100. The medication consumption tracking (fisheye) camera172can be any suitable camera, including a standard video camera, a zoom lens capability camera, a camera in a motorized mount, a camera in a motorized mount being remotely controlled, an infrared camera, a night-vision camera, or any other suitable video acquisition system. One or more light emitting elements178can be integrated into the narcotics and Opioids secure storage and dispensing apparatus100at a location proximate the dispense compartment116. The light emitting elements178are provided to emit light towards the dispensing location, which can additionally support acquisition of video using the medication dispense monitoring camera174.

One of the goals of the narcotics and Opioids secure storage and dispensing apparatus100is to enable a process for tracking the dispensing and ingestion of the medication119,129. A first optional process employs the GPS/GNSS341. The inclusion of a GPS/GNSS341(FIG.45) enables the narcotics and Opioids secure storage and dispensing apparatus100to identify a date, time, and location of the narcotics and Opioids secure storage and dispensing apparatus100during a specific event. The narcotics and Opioids secure storage and dispensing apparatus100can include an instruction set (stored in the memory module320) to record the date, time and location when the medication119,129is dispensed and/or ingested. The date, time, and location can be associated with other information acquired during the dispensing and/or ingesting of the medication119,129, such as video of the dispensing and/or ingestion process. The acquisition of medication dispensing documentation can be programmed by the manufacturer of the narcotics and Opioids secure storage and dispensing apparatus100, a caregiver, a medical professional, or any other authorized person. A second optional process employs a gel-coating that can be used to encapsulate the medication119,129. A sensor would be embedded within the gel-coating, wherein the sensor would verify that the medication119,129is placed in the mouth of the user for ingesting.

The storage/charging cart/station are illustrated inFIGS.15through19. The storage cart250is shown comprising one or more storage shelves260to place and dock the narcotics and Opioids secure storage and dispensing apparatus100. The storage cart further provides charging contacts for each storage shelf to allow charging the narcotics and Opioids secure storage and dispensing apparatus100while being docked. While the narcotics and Opioids secure storage and dispensing apparatus100are docked in the cart shelves210, the storage cart further employs the charging contacts212to access, log and report the ID, configuration information on each narcotics and Opioids secure storage and dispensing apparatus100, as well as the medication dispensed from the primary medication tray110, the secondary medication tray120and the sealed blister pack160.

The storage cart250is preferably portable and would include a plurality of casters. Alternatively, mobility of the storage cart250can be provided by integrating powered wheels, including a steering mechanism. The mobility of the storage cart250can be user operated, automated, or a combination thereof.

Each storage cart250comprises of one or more storage shelves210to place and dock the narcotics and Opioids secure storage and dispensing apparatus100. The charging contacts212within each storage shelf260of the storage cart250allow charging of the narcotics and Opioids secure storage and dispensing apparatus100while being docked. The charging contacts262within each storage shelf210further provides the connection circuitry for the storage cart250to access, log and report the ID, configuration information on each narcotics and Opioids secure storage and dispensing apparatus100, as well as the medication dispensed from the primary medication tray110, the secondary medication tray120and the sealed blister pack160.

The storage cart (docking station)250can additional include a storage cart interactive system270. The storage cart interactive system270can incorporate a display (preferably a touch display), a speaker, a microphone, and any other user interface devices, such as a keyboard, a pointing device, or any other suitable user interface devices. The storage cart interactive system270can be assembled to the storage cart (docking station)250using hinges enabling the storage cart interactive system270to be rotated between an upright (vertical) orientation and a lowered (horizontal) orientation.

An ankle/wrist controlled medication dispensing bracelet200is an alternate form of the narcotics and Opioids secure storage and dispensing apparatus100. The ankle/wrist controlled medication dispensing bracelet200is provided in a form factor of a bracelet in order to provide mobile dispensing and monitoring of the Opioids usage and adherence. The ankle/wrist controlled medication dispensing bracelet200can be configured to be placed on the user's wrist as an controlled medication dispensing bracelet200. Alternatively, the ankle/wrist controlled medication dispensing bracelet200can be configured to be placed on the user's ankle.

Each ankle/wrist controlled medication dispensing bracelet200comprises of one or more medication compartments210which will contain the medication to be dispensed at scheduled time. Each medication compartment210of the controlled medication dispensing bracelet200comprises of a compartment door212, a compartment door motor214, and motor controller circuitry358to securely open and close the respective compartment door212.

Each medication compartment210of ankle/wrist controlled medication dispensing bracelet200comprises a compartment door212, a motorized mechanism358, and an actuating door motor214.

The actuating door motor214and the associated supporting motor controller circuitry358are provided for each bracelet medication compartment door212to securely open and close the respective compartment door212.

The bracelet band230is configured to support a main bracelet control unit220and a plurality of the bracelet medication compartments210.

The bracelet docking magnets provide contact points between the controlled medication dispensing bracelet200and the narcotics and Opioids secure storage and dispensing apparatus100.

The main bracelet control unit220comprises a touch display unit222which provides interactive communication between the controlled medication dispensing bracelet200) with the bracelet artificial intelligence Avatar assistant224. The bracelet touch display222can also provide video communication between the user and the remote operators and caregivers.

The main bracelet control unit220comprises of a touch display unit222which provided interactive communication between the controlled medication dispensing bracelet200with the bracelet artificial intelligence Avatar assistant224. The artificial intelligence virtual Avatar assistant224of the current invention, Opioids bracelet200utilizes text to speech, speech to text and Natural Language Processing (NLP)326technology to interactively communicate with the user, triage the user and gather relevant information regarding user's health status.

The main bracelet control unit220comprises of a touch display unit222which provided interactive communication between the controlled medication dispensing bracelet200with the bracelet artificial intelligence Avatar assistant224.

The narcotics and Opioids secure storage and dispensing apparatus charging contacts139, which are detailed inFIGS.32through36, connects to the charging contacts212within each storage shelf210of the storage cart250to allow charging the narcotics and Opioids secure storage and dispensing apparatus100while being docked. The charging contacts139further provide the storage cart250with access, log and report the ID, configuration information on each narcotics and Opioids secure storage and dispensing apparatus100, as well as the medication dispensed from the primary medication tray110, the secondary medication tray120and the sealed blister pack160.

The secondary mediation tray cover124further comprises of a microphone136which allows the artificial intelligence Avatar assistant224as well as the remote operators and caregivers to interactively communicate with the user. The secondary mediation tray cover124further comprising a speaker134which allows the artificial intelligence avatar assistant224as well as the remote operators and caregivers to interactively communicate with the user. The primary medication tray110comprises of multiple medication compartments112containing the Opioids and other medications for one or more time instances during a day such as morning, noon, afternoon and evening, as well as one or more days of the week. The secondary medication tray120comprises of multiple medication compartments122containing vitamins, supplemental medication and new additions to regular medication contained in the primary medication tray110.

The microphone136can continuously monitor for sound. When the microphone136records a sound that the microprocessor310determines to be unusual, the microphone136continues to record, but the recording is saved.

An electronic block diagram representative of the narcotics and Opioids secure storage and dispensing apparatus300is presented inFIG.37. The block diagram comprises of a microcontroller310, a memory module320, a power management system330, a wireless module340, a motor controller350, a user interface360and a sensory system370.

The memory module320includes a storage area for the program322, a database324, text to speech (TTS), speech to text (STT) and Natural Language Processing (NLP)326as well as storage area for triage data328.

The power management module330includes a battery332, a docking station interface334, a charging circuitry336and a bracelet interface338.

The wireless module340includes cellular transmission circuitry342for 2G, 3G, 4G and 5G, Wi-Fi circuitry344, Bluetooth circuitry346and RFID circuitry347. The wireless module340can additionally include a Global Positioning System (GPS)/Global Navigation Satellite System (GNSS) receiver348(FIG.46) and an antenna349(FIG.46).

The motor controller module350includes motor control circuitry for a primary tray352, a secondary tray354, a punch lever356, a bracelet door358and a dispense door359.

The user interface module360includes a display controller362, buttons364, a speaker and a microphone366, and a mobile device368.

The sensory system module370contains circuitry for various optical and mechanical sensors.

It is critical that the narcotics and Opioids secure storage and dispensing apparatus100is configured to dispense the medication while ensuring against unwarranted access to the medication. This is of particular interest when dealing with narcotics, Opioids, and other schedule II drugs. Security for the narcotics and Opioids secure storage and dispensing apparatus100can be provided employing a number of features. Unwarranted access to the encase medication can be prevented using a security elements as introduced inFIG.44. The exemplary security elements include a motion sensor372and a noise sensor374. The motion sensor372can be arranged to detect general unwarranted motion as well as sudden impact or shock, generally indicative of unwarranted motion of the narcotics and Opioids secure storage and dispensing apparatus100. This can include a person trying to gain access to the contained medication by breaking the enclosure, the top cover114, the secondary medication tray cover124, or any other enclosing feature of the narcotics and Opioids secure storage and dispensing apparatus100. The noise sensor374can be arranged to detect general unwarranted noise, generally indicative of breakage of the enclosure of the narcotics and Opioids secure storage and dispensing apparatus100. Other sensing devices can be employed to identify when an unwarranted activity is taking place respective to the narcotics and Opioids secure storage and dispensing apparatus100. For example, strain gauges can be installed at potential pry points or other locations that might identify when the enclosure is being subjected to an unwarranted force. Each of the sensors would directly or indirectly provide a signal to the microprocessor310. Power to the system is provided by the battery332, a corded power source, a solar power source, or any other suitable power source. The microprocessor310can operate in accordance with an instruction set that monitors for any signals from the sensors that exceed a normal range. Upon identification of a scenario where a sensor generated a signal that exceeds the normal range or any other signal that is determined to be suspect, the microprocessor310would initiate an alert. The alert can include a local alert, such as a light and/or an audible alarm emitted through the speaker134(such as in a form of a siren or other high pitch sound generator), a remote alert by transmitting a signal to a remote receiver using the wireless module340, or activating any other alerting function, or any combination thereof. The transmitted signal can include information identifying which sensor or sensors are providing a signal suggesting a suspect activity on the narcotics and Opioids secure storage and dispensing apparatus100as well as a location identified by a Global Positioning System (GPS) or a Global Navigational Satellite System (GNSS)341. A GPS/GNSS antenna349would be included to support the GPS/GNSS341system. Additionally, the narcotics and Opioids secure storage and dispensing apparatus100can activate the medication consumption tracking (fisheye) camera172and the microphone136to record both video and audio following the unwarranted motion. Although the above is directed towards the narcotics and Opioids secure storage and dispensing apparatus100, the same can be applied to the controlled medication dispensing bracelet200.

A first scale376can be integrated into the narcotics and Opioids secure storage and dispensing apparatus100, wherein the first scale376would be located proximate the dispense compartment116, where the first scale376can acquire a weight of the medication119,129staged for dispensing. A second scale376can be integrated into the narcotics and Opioids secure storage and dispensing apparatus100, wherein the second scale376would be located at a medication reclamation safe180(FIGS.46-53) within the narcotics and Opioids secure storage and dispensing apparatus100, where medication119,129that is not dispensed would be transferred to the medication reclamation safe180within the narcotics and Opioids secure storage and dispensing apparatus100and weighed using the scale376. Every step would preferably include a process of weighing the medication119,129using one or more scales376to track each transfer of the medication119,129. Weight of each pill119,129is available from the manufacture and can be acquired using the wireless module340and stored within the memory module320. Non-dispensed medication119,129would be stored in the medication reclamation safe180awaiting diversion/destruction by Drug Enforcement Agency (DEA) (or other authorizing) certified facility. This function enables another important verification that no pill can ever be lost or go missing through any stage of handling by the narcotics and Opioids secure storage and dispensing apparatus100, the user, or any other persons.

The medication would remain in the dispense compartment116until one of two conditions:(a) dispensing of the primary medication119is appropriate. This can be based on a scheduled time for dispensing, a request by the user for dispensing of the primary medication119, a request by the user for dispensing of the primary medication119that is approved by an authorizing process (either the system or a decision by an authorized person), or any other acceptable condition,(b) dispensing of the primary medication119is determined to be inappropriate. In this condition, the staged primary medication119can be forwarded to the medication reclamation safe180. Conditions can include when a time window for dispensing of the primary medication119has lapsed without a request for dispensing of the primary medication119, the user fails to meet criteria suitable for prescribing taking of the primary medication119, or any other scenario where it would be determined inappropriate for the user to take the primary medication119. In one scenario of this condition, it could be determined to reclaim the primary medication119and to dispense the supplemental medication129, wherein the primary medication119would be transferred to the medication reclamation safe180and the supplemental medication129would be transferred to the116# for dispensing.

Operation of one exemplary medication reclamation system is illustrated inFIGS.48through51. The primary medication119is dispensed into the dispense compartment116(as illustrated inFIG.48), where the primary medication119would come to rest upon an upper surface of the medication dispensing door170(as illustrated inFIG.49). In a condition where it is determined to reclaim the primary medication119, a reclamation safe pill collection sweeper186is operated to transfer the primary medication119from the dispense compartment116to a reclamation safe repository184of the reclamation safe180. In the exemplary illustrations, the reclamation safe pill collection sweeper186is provided in a form of a rotating sweeper that rotates about the upper surface of the medication dispensing door170. One or more walls (not shown for clarity) can be provided to encapsulate the dispense compartment116, while enabling operational motion of the reclamation safe pill collection sweeper186. The reclamation safe pill collection sweeper186would continue to move, transferring the primary medication119from the dispense compartment116to a position over the reclamation safe repositing aperture182of the reclamation safe180. The primary medication119would drop through the reclamation safe repositing aperture182, into the reclamation safe repository184(as illustrated inFIG.51). In the exemplary illustrated version of the medication reclamation system, the reclamation safe pill collection sweeper186rotates about a reclamation safe pill collection sweeper rotational axis187. Although the exemplary reclamation safe pill collection sweeper186is illustrated as a rotating member, the reclamation safe pill collection sweeper186can be designed to move in accordance with any suitable motion, including a rotating motion, a hinged motion, a sliding motion, and the like. A reclamation safe repository cover (not shown for clarity) can be integrated into a portion of the reclamation safe pill collection sweeper186between two adjacent sweeping elements to adequately seal the reclamation safe repositing aperture182when the reclamation safe pill collection sweeper186is not operating. At a desired time, collected primary medication119can be recovered from the reclamation safe180using any suitable access process. This can include a mechanical lock, an electronic lock, or any other suitable controlled access system.

A scale376can be integrated into the reclamation safe180to track a weight of the primary medication119being deposited within the reclamation safe repository184.

A track me process400for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.38. The track me process400begins (step410) with a decision step to determine whether the track me process400is enabled (decision step420). If the track me process is not enabled, then the track me process400terminates (step422). If the track me process400is enabled, then the track me process400continues within a continuous loop. A geo-fence for the narcotics and Opioids secure storage and dispensing apparatus100is established (step430), followed by a setting of a geo-fence for the Opioids bracelet200(step432). Next, Global Positioning System (GPS) locations are checked to see if the any of the narcotics and Opioids secure storage and dispensing apparatuses100or the controlled medication dispensing bracelets200cross their respective geo-fences (decision step440). If geo-fence has not been crossed (decision step440), then the process loops back and continues setting the geo-fence area (steps430,432) and checking to see if either device has crossed the designated area (decision step440). In the event that geo-fence is crossed (decision step440), notifications are sent to remote operators and caregivers (step442). The process again, loops back and continues setting the geo-fence area (steps430,432) and checking to see if either device has crossed the designated area (decision step440). In one option, in a condition where the geo-fence has been breached, the narcotics and Opioids secure storage and dispensing apparatus100would lock and transmit a notification to at least one recipient that the narcotics and Opioids secure storage and dispensing apparatus100has breached the geo-fence.

A locate me process500for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.39. The locate me process500begins (step510) with a check as to whether the process is enabled390b(decision step520). If the locate me process500is not enabled, then the process terminates (step522). If the process is enabled, the locate me process500then enters a continuous loop which sends a notification of the Opioids Dispenser GPS location (step530). This is followed by a step of sending a notification of the Opioid Bracelet GPS location (step532).

A schedule medication process600for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.40. The schedule medication process600begins with an activation of the schedule medication interface (step610) in a condition where the schedule medication process600is enabled. The schedule medication process600checks for the availability of a medication tray in the primary medication compartment and the secondary medication compartment.

Medication can be loaded independently into the narcotics and Opioids secure storage and dispensing apparatus100or inserted in a prefilled blister pack160. The primary medication scheduling process600identifies which tray is going to be dispensing the medication (decision step620).

The primary medication scheduling checks for a blister pack160(step622). If there is no blister pack160, the primary medication scheduling process prompts a loading of a blister pack (step640). The primary medication scheduling process prompts for the selection of the medication (step642). After selection the medication (step642), the primary medication scheduling process600then prompts for a dosage selection (step644). The primary medication scheduling process600prompts for an addition of any special instructions (step646). Next, the schedule medication process600prompts for the selection of a date and a time for administration of the medication (step637). The next prompt pops up, requesting entry to setting reminders as to when to take the medication (step648). The primary medication scheduling process600then prompts for adding medication (step649).

If there is a blister pack160contained in the primary medication tray110(as determined by decision step622), the schedule medication process600will ask for a selection of the medication (step630). After that, the schedule medication process600will then prompts for entry of a dosage selection (step632). The schedule medication process600prompts for the addition of any special instructions (step634). Next, the schedule medication process600prompts for the selection of a date and a time for administration of the medication (step636). The next prompt is for setting reminders as to when to take the medication (step638). The schedule medication process600then presents a prompt for adding medication (step639).

The secondary medication scheduling portion involves selecting the supplemental medication (step650). After the supplemental medication has been set, the secondary medication scheduling portion prompts for a dosage selection (step652). After the dosage selection has been completed, the secondary medication scheduling portion prompts for the addition of any special instructions (step654). After entry of any special instructions has been completed, the secondary medication scheduling portion prompts the selection of a date and time for dispensing the supplemental medication and links the scheduled date and time for dispensing the supplemental medication with the scheduled date and time for dispensing the medication from the primary tray medication (step656). After that has been completed, the secondary medication scheduling portion prompts for the addition of reminders (step658). After that is done, the secondary medication scheduling portion prompts for the refill or addition of supplemental medication (step659).

A dispense medication process700for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.41. In a high level summary, the dispense medication process700involves a step of determining the dispense day and time (step720), validation of the user (step730), dispensing from the primary tray (step750) and finally linking supplemental medication (steps760,762,764). The dispense medication process700begins with a check to determine whether the process is enabled (step710). If the process is enabled (step710), then the dispense medication process700checks for the date and time (step720). If it is not time for administration of a medication then the process terminates (step722). If dispense medication process700determines that it is time for the medication the dispense medication process700the dispense medication process700proceeds to validate the user taking the medication (step730). If the validation fails, the process terminates and nothing happens (step742). If the validation is successful (decision step740) the dispense medication process700dispenses medication from the primary tray (step750). After dispensing the medication from the primary tray (step750), the dispense medication process700checks if any supplemental medication is linked (decision step760). If no supplemental medication is linked, the process terminates (step762). If any supplemental medication is linked, the dispense medication process700dispenses the supplemental medication (step770).

Referring toFIG.42shows a transport meds to bracelet process800for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.42. In the transport meds to bracelet process800, a bracelet200is enabled and the docked bracelet200is verified prior to dispensing any primary tray medication. The transport meds to bracelet process800initiates (step810), then determines if transporting the medication from the narcotics and Opioids secure storage and dispensing apparatus100to the controlled medication dispensing bracelet200is authorized. If the transfer of medication is not authorized, the process terminates (step822). If the transfer of medication is authorization, the transport meds to bracelet process800proceeds to detect if a bracelet200is docked (decision step830). If the decision step830determines that a bracelet200is not docked, then the process terminates (step832). If a docked bracelet200is detected, the transport meds to bracelet process800logs the bracelet identifier and the bracelet compartment number receiving the medication (step840). The transport meds to bracelet process800activates a motor to open the bracelet compartment door212(step842). Then, the primary medication tray110is selected (step844). Next, medication is dispensed from the primary medication tray110into the bracelet200(step846). Continuing, the transport meds to bracelet process800checks if supplemental medication is linked (decision step850). If supplemental medication is not linked to the primary medication, the transport meds to bracelet process800activates the motor to close the bracelet compartment door212(step852), and the transport meds to bracelet process800terminates (step854). If there is a link between primary medication and supplemental medication, the transport meds to bracelet process800dispenses the supplemental medication accordingly (step860).

A dispense meds from bracelet process900for use in conjunction with the narcotics and Opioids secure storage and dispensing apparatus100is presented inFIG.43. The dispense meds from bracelet process900determines if a controlled medication dispensing bracelet200is enabled (decision step920), followed by a step of determining a dispense time (step930). As soon as a user validation process (step940) is completed, a motor is activated to open the bracelet compartment door212(step964) and medication within the respective compartment is taken prior to closing the bracelet compartment door212. The dispense meds from bracelet process900dispense meds from bracelet process900initiates with a step of checking for the availability of medication (step910). The dispense meds from bracelet process900then checks to verify that the controlled medication dispensing bracelet200is enabled (decision step920). If the controlled medication dispensing bracelet200is not enabled, then the process terminates (step922). If the controlled medication dispensing bracelet200is enabled, the dispense meds from bracelet process900checks for a dispensing time (step930). If the dispense meds from bracelet process900determines that it is not the correct time for administration of the medication (decision step920), then the process terminates (step932). If the dispense meds from bracelet process900determines that it is the correct time (or within a correct window of time) for dispensing the medication, the dispense meds from bracelet process900proceeds to validate the user (step940). Validation of the user can be accomplished using any suitable process. Two exemplary processes include use of a biometric sensor (finger print reader, hand reader, palm reader, and the like) (step942) and/or use of a facial recognition process (step944). It is understood that any number of user verification processes can be employed, including those mentioned, as well as voice recognition, iris scanner, and the like. The dispense meds from bracelet process900then determines whether if the process validated the user (decision step950). If the user is not validated (decision step950), then the process terminates (step952). If the user is validated (decision step950), the dispense meds from bracelet process900proceeds to dispense medication from the primary tray116(step960). To accomplish the dispensing process (step960), the dispense meds from bracelet process900asks to select the bracelet compartment (step962). The dispense meds from bracelet process900activates the motor to open the respective bracelet door (step964). The dispense meds from bracelet process900proceeds with a decision step to determine if the medication has been ingested (decision step970). If process determines that the medication hasn't been ingested (decision step970), the dispense meds from bracelet process900loops back to ensure the door to the respective bracelet compartment is open (step964). If the dispense meds from bracelet process900determines that the medication was taken, the dispense meds from bracelet process900activates the motor to close the bracelet door (step972). The process terminates (step974).

The inclusion of two distinct trays, each tray filled with a respective set of medication, provides a unique advantage when dealing with certain types of medication, including by not limited to narcotics, Opioids, other highly addictive medication, and the like. The additional inclusion of a user interface (such as the artificial intelligence avatar132) enables the narcotics and Opioids secure storage and dispensing apparatus100to acquire additional information from the patient. The narcotics and Opioids secure storage and dispensing apparatus100can acquire information pertaining to the patient and use that information to determine whether it is appropriate to dispense the narcotics. In one example, the primary medication tray110can be filled with prescribed narcotics, and the secondary medication tray120can be filled with less addictive medications. In a condition where the narcotics and Opioids secure storage and dispensing apparatus100acquires information from the patient that introduces suspicion that the narcotic or Opioid is actually medically necessary (as opposed to being requested to support an addiction), the narcotics and Opioids secure storage and dispensing apparatus100can dispense medication from the secondary medication tray120. This can be determined by intelligence within the narcotics and Opioids secure storage and dispensing apparatus100, sending acquired patient input to a prescribing physician, or any other suitable decision making process. Details of an application of the dual tray benefits of the narcotics and Opioids secure storage and dispensing apparatus100are presented in an exemplary medication dispensing triage process1000described inFIGS.44A and44B.

The exemplary medication dispensing triage process1000can be initiated (step1010) via a request to dispense medication (step1020). The request can be via a dispense medication request button (not shown), a request through the interactive system, through an application on a mobile device, or any other method of requesting dispensing of medication. Upon initiation of the request to dispense medication (step1020), the process determines of the request is being submitted within prescribed dispense time (decision step1030). This is preferably accomplished via software operating on the microprocessor310. In a condition where the request is submitted within prescribed dispense time (decision step1030), the narcotics and Opioids secure storage and dispensing apparatus100dispenses the medication from the primary medication tray110(step1032) and subsequently terminates the process (step1034). In a condition where the request is submitted outside of the prescribed dispense time (decision step1030), the process notifies an associated user counselor and/or physician(s) (step1036). In a preferred scenario, the process would notify all parties associated with the treatment of the user, including the user's counselor, the user's medical team, and any other parties involved in the treatment of the user (step1036). The process would then prompt the user to enter/answer information to determine a validity for dispensing of primary medication at the requested time (step1038). The user would respond by entering the requested information to determine the validity for dispensing of primary medication at the requested time (step1039). The requested information can additionally include a request for medical data, such as a urine specimen. The urine specimen can be obtained and processed through a portable urine tester (not shown) that would interact with the narcotics and Opioids secure storage and dispensing apparatus100. Another optional test would be a breathalyzer for testing of alcohol. It is understood that any suitable testing device can interact with the narcotics and Opioids secure storage and dispensing apparatus100to acquire medical information pertaining to the user. Other examples include a blood pressure monitor, a glucose monitor, and the like.

Upon receipt of the responses to the requested information to determine the validity for dispensing of primary medication at the requested time (step1039), the responses are reviewed to determine whether the responses to the requested information to determine the validity for dispensing of primary medication at the requested time (step1039) justify a condition for dispensing of primary medication at the requested time (decision step1040). The decision can be completed by a person or the automated system. The automated system can employ artificial intelligence, wherein the artificial intelligence is developed by learning from previous decisions and results. When determined that the conditions for dispensing of primary medication at the requested time (decision step1040) are valid, the appropriate medication is dispensed from the primary medication tray110(step1042) and the process terminates (step1044).

When determined that the conditions for dispensing of primary medication at the requested time (decision step1040) are not valid, the system can proceed to determine if the situation warrants dispensing of medication from the secondary medication tray120(decision step1050) and/or notification of the prescription counselor of the request for dispensing of medication and the submitted reasons for the request (step1060). When the situation warrants dispensing of medication from the secondary medication tray120(decision step1050), the narcotics and Opioids secure storage and dispensing apparatus100proceeds with dispensing of medication from the secondary medication tray120(step1052) and the process terminates (step1054). An example would be dispensing of a non addictive (non-habit forming) prescription or non-prescription analgesic drug when the user requests dispensing of an addictive class II drug (such as narcotics, Opioids and the like). When the situation does not warrant dispensing of medication from the secondary medication tray120(decision step1050), the process terminates (step1056).

The narcotics and Opioids secure storage and dispensing apparatus100is designed to ensure that the user is monitored by appropriate parties during the period of use of the narcotics and Opioids secure storage and dispensing apparatus100. The notification of the prescription counselor of the request for dispensing of medication and the submitted reasons for the request (step1060) ensures that the user is adequately monitored by appropriate parties during the period of use of the narcotics and Opioids secure storage and dispensing apparatus100.

Upon notification, the counselor for the user would determine a need for a plan for the patient (user) (decision step1070). In a condition where the counselor determines that the conditions warrant dispensing of medication from the primary medication tray110the narcotics and Opioids secure storage and dispensing apparatus100proceeds in dispensing medication from the primary medication tray110(step1090) and the process terminates (step1092).

In a condition where the counselor determines that the conditions warrant generation of a plan, the counselor determines an appropriate patient treatment plan (step1072) and the process proceeds in accordance with the appropriate patient treatment plan (step1074). The plan may include dispensing of medication. The plan can direct dispensing of primary medication, dispensing of supplemental medication, or both.

In a condition where the plan includes dispensing of medication from the primary medication tray110(decision step1076), the narcotics and Opioids secure storage and dispensing apparatus100proceeds in dispensing medication from the primary medication tray110(step1078) and the process terminates (step1079). In a condition where the plan includes dispensing of medication from the secondary medication tray120(decision step1076), the narcotics and Opioids secure storage and dispensing apparatus100proceeds in dispensing medication from the secondary medication tray120(step1080) and the process terminates (step1082).

In a condition where the counselor determines that the conditions warrant dispensing of medication from the primary medication tray110(decision step1070) exclusive of a requirement for generating an appropriate treatment plan (step1072) the narcotics and Opioids secure storage and dispensing apparatus100proceeds in dispensing medication from the primary medication tray110(step1090) and the process terminates (step1092).

The narcotics and Opioids secure storage and dispensing apparatus100includes a patient interactive system and two trays110,120carrying differing levels of drugs. This combination provides a unique capability to support a patient/user taking class II medication and/or potentially an addiction. The narcotics and Opioids secure storage and dispensing apparatus100enables dispensing of the class II medication from the primary medication tray110or alternative, non-addictive medication from the secondary medication tray120upon an intelligence decision. Additionally, the narcotics and Opioids secure storage and dispensing apparatus100is adapted to enable treatment of an accidental overdose.

An exemplary narcotics and Opioids secure storage and dispensing apparatus100, a controlled medication dispensing bracelet200, and an associated method of use are described herein. Although the apparatus and methods taught herein are the preferred and alternate embodiments, it can be recognized that other form factors, materials, and methods of achieving the same results can be contrived from the disclosed teachings. The narcotics and Opioids secure storage and dispensing apparatus100as well as the controlled medication dispensing bracelet200can be modified to include differing features, a different shape, different user interface devices, activity indicators, such as lights, or any other desired feature and/or function, functions of the narcotics and Opioids secure storage and dispensing apparatus100can be integrated in the controlled medication dispensing bracelet200. For example, the rotary design of the narcotics and Opioids secure storage and dispensing apparatus100can be arranged in a linear arrangement, where the dispensing mechanism travels along a linear guide. In another example, the controlled medication dispensing bracelet200can store the suspected overdose counteracting drug148in one of the available bracelet medication compartments210.

REFERENCE ELEMENT DESCRIPTIONS

Ref No. Description100narcotics and Opioids secure storage and dispensing apparatus110primary medication tray112primary tray medication compartment114top cover116dispense compartment117dispensing chute118punch lever120secondary medication tray122secondary tray medication compartment124secondary medication tray cover129supplemental medications, vitamins and other pills130display unit132artificial intelligence avatar134speaker136microphone138panic button139narcotics and Opioids secure storage and dispensing apparatus charging contacts140front supporting leg141front supporting leg storage access element142rear supporting leg143front supporting leg storage access148suspected overdose counteracting drug150sliding shafts152secondary tray cover locking harness154dual tray cover interconnected locking shaft160sealed blister pack162blister pack medication compartments170medication dispensing member172medication consumption tracking (fisheye) camera174medication dispense monitoring camera176biometric monitoring sensor178light emitting element180reclamation safe182reclamation safe repository aperture184reclamation safe repository186reclamation safe pill collection sweeper187reclamation safe pill collection sweeper rotational axis200controlled medication dispensing bracelet210bracelet medication compartment212bracelet compartment door214bracelet compartment door motor220main bracelet control unit222bracelet touch display unit224bracelet artificial intelligence Avatar assistant230bracelet band250storage cart (docking station)260storage shelf262charging contacts270storage cart interactive system300secure storage for dispensing of Opioids electronic block diagram310microprocessor320memory module322program324database326text to speech (TTS), speech to text (STT) and Natural Language Processing (NLP)328storage area for triage data330power management system332battery334docking station interface336charging circuitry338bracelet interface340wireless module342cellular transmission circuitry344Wi-Fi circuitry346Bluetooth circuitry347RFID circuitry348Global Positioning System (GPS)/Global Navigation Satellite System (GNSS) receiver349antenna350motor controller352for a primary tray motor control circuitry354secondary tray motor control circuitry356punch lever motor control circuitry358bracelet door motor control circuitry359dispense door motor control circuitry360user interface362display controller364button366speaker and a microphone368mobile device370sensory system372motion sensor374noise sensor376digital scale400track me process410track me process initiation step420track me process enabled decision step422termination step430establish geo-fence for the narcotics and Opioids secure storage and dispensing apparatus step432establish geo-fence for the Opioid dispensing bracelet step440device crosses geo-fence boundary decision step442send notification to remote operators/caregivers step500locate me process510locate me process initiation step520locate me process enabled decision step522termination step530send notification step with dispenser GPS location step532send notification step with bracelet GPS location step600schedule medication process610schedule medication process activation step620determine which tray is dispensing medication decision step622determine if a blister pack is being used decision step630request entry of desired medication step632request entry of dosage of medication step634request entry of any additional instructions step636selection date and time for administration of medication step638setting reminder when to take medication step639prompt to refill medication step640prompt loading of blister pack step642request entry of desired medication step644request entry of dosage of medication step646request entry of any additional instructions step647selection date and time for administration of medication step648setting reminder when to take medication step649prompt to refill medication step650prompt to select supplemental medication step652prompt for a dosage selection of the secondary medication654prompt special instructions associated with supplemental medication step656prompt selection and linking to the associated primary tray medication date and time658prompt to add reminders659prompt to refill supplemental medication step700dispense medication process710dispense medication process initiation step720determining the dispense day and time step722termination step730acquire validation of the user ingesting medication step740validation of the user ingesting medication decision step742termination step750dispense medication from primary tray step760supplemental medication linked decision step762termination step770dispense medication from secondary tray step800transport meds to bracelet process810transport meds to bracelet process initiation820medication dispensing bracelet822termination step830bracelet docked decision step832termination step840log bracelet compartment number step842activate motor to open bracelet compartment door step844select primary medication tray step846dispense medication from primary tray to bracelet step850determine if supplemental medication is linked decision step852activate motor to close bracelet compartment door step854termination step860dispense supplemental medication step900dispense meds from bracelet process910dispense meds from bracelet process initiation920bracelet enabled decision step922termination step930determine dispense time decision step932termination step940user validation process step942biometric sensing process944facial recognition process950user validated decision step952termination step960dispense medication from primary tray step962identify bracelet compartment to dispense medication step964activate motor to open bracelet compartment door step970determine if medication has been injected972activate motor to close bracelet compartment door step974termination step1000medication dispensing triage process1010medication dispensing triage process initiation1020user requests dispensing medication step1030request within prescribed dispense time decision step1032dispense medication from primary tray step1034termination step1036notify counselor and/or physicians step1038prompt dispense validity status information acquisition step1039enter dispense validity status information step1040validate reasons for prescribing medication decision step1042dispense medication from primary tray step1044termination step1050dispense supplemental medication decision step1052dispense supplemental medication step1054termination step1056termination step1060inform prescription counselor step1070counselor determines need for patient plan decision step1072determine appropriate patient treatment plan step1074proceed with appropriate patient treatment plan step1076approval to dispense primary medication decision step1078dispense medication from primary tray step1079termination step1080dispense medication from secondary tray step1082termination step1090dispense medication from primary tray step1092termination step